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ABSTRACT
Aim: This study aims to investigate the ability of
patients’ baseline characteristics to predict the distance
walked during the incremental shuttle walk test (ISWT)
in the cardiac rehabilitation (CR) population and to
produce reference values to guide practice.
Methods: Secondary analysis was conducted on
National Audit Cardiac Rehabilitation data collected
between 2010 and 2015. Patients (n=8863) were
included if they were aged 18 years and had a
recorded ISWT score assessed before starting CR.
Stepwise regression was used to identify factors
predicting the ISWT distance. Age, gender, body mass
index, height, weight; presence of hypertension,
dyslipidemia or diabetes; smoking and physical activity
were independent variables. ISWT distance was the
dependent variable. The 25th, 50th and 75th
percentiles of the ISWT distance were used as
reference values.
Results: Age and gender explained 27% of the
variance of the distance covered in the ISWT (R2=0.27,
adjusted R2=0.27,Standard Error of the Estimate (SEE)
= 148.7, p<0.001). Reference values using age and
gender categories were developed.
Conclusion: Age and gender were the significant
factors for predicting the walking fitness in the CR
population, with age being the best predictor. The age
and gender reference values produced represent a
potentially valuable tool to be used in the clinical
setting.
INTRODUCTION
Assessing physical fitness at baseline and
end of programme in patients attending
cardiac rehabilitation (CR) is strongly
recommended in clinical guidelines and
national standards.1–3 Assessing a patient’s
fitness level at the beginning of the
programme enables the appropriate inten-
sity of exercise to be prescribed, determines
the level of supervision and monitoring
required and allows for the assessment of
the effectiveness of the intervention.3 4
Using laboratory maximal tests on tread-
mills or cycle ergometers to assess
cardiorespiratory fitness by directly
measuring the maximal oxygen uptake (Vo2
max or Vo2 peak) is regarded as the gold
standard. However, these tests are not
widely available.1 5 Compared with the gold
standard methods, functional fitness walk
tests are simple and safe to use and are a
reasonable surrogate measure of fitness.6 In
the UK, the most commonly used field test
in CR and chronic obstructive pulmonary
disease patients is the incremental shuttle
walk test (ISWT), which is an objective test
widely used in clinical settings to assess the
extent of physical fitness.5 6 This type of
test is shown to be reliable and strongly
correlated with the cardiopulmonary exer-
cise test (CPET).7 8 The ISWT is a
submaximal, incremental, externally paced
test that evaluates physical fitness based on
the distance covered during the assess-
ment.6 8 The recommended protocol is a
20min test followed by a 30min rest period
before the test is repeated. The best
outcome of the two tests is then recorded.
However, in routine clinical practice, the
ISWT is generally performed just once
despite emerging research suggesting that
the learning effect may influence the
distance achieved as evidenced through a
second baseline test.9 Most CR programmes
struggle to carry out even a single baseline
fitness test,10 which makes undertaking a
second test unrealistic. To date, very few
studies have tried to establish reference
values as a comparison with the first ISWT
attempt, and where it has been attempted,
the sample size has been insufficient within
the proposed categories.11 12
Healthy individuals have been shown to
walk double the distance of patients with
cardiac disease during the ISWT (600–800
m vs 300–400 m, respectively).11 Predicting
the distance covered during the ISWT has
been attempted in several studies in healthy
populations13–17; however, to date, only two
studies have been published using a CR
population.11 12 These two studies
conducted by Pepera et al (2013) and
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Cardoso et al (2016) explained 20% and 25%, respec-
tively, of the variance in distance walked, and the latter
study attempted to produce reference values for CR
patients. Age, height, body mass index (BMI) and the
presence of diabetes were found to be significant
predictors in the study by Cardoso et al while Pepera
et al found only height and BMI to be significant.
However, the limited number of female participants
and the small number of centres used limit the gener-
alisability and clinical usefulness of these results. The
need for reference values remains important as they
could help reduce or even eliminate the need to do the
ISWT a second time and could be used as feedback for
patients in respect of their level of fitness.
The aims of this study were (1) to identify any addi-
tional important predictors, beyond age and gender, of
the distance covered during the ISWT at baseline, (2)
to produce reference values for the distance walked by
CR patients during the ISWT and (3) to propose an
approach for benchmarking performance following the
test. This information has the potential to be used to
guide clinical practitioners’ expectations of the
patients’ performance in an ISWT and help them set
realistic CR goals.
METHODS
This observational study was reported according to the
Strengthening the Reporting of Observational Studies
in Epidemiology.18
Data collection
Secondary analysis was conducted using anonymised
individual patient data from the National Audit
Cardiac Rehabilitation (NACR) database from 2010 to
2015. NACR is a national quality-assurance project
which is designed to ensure that the optimum CR
outcomes are achieved with patients with cardiovas-
cular disease and that the CR programmes follow good
practice as defined by the clinical minimum stand-
ards.10 19 The NACR data are collected under 251
approval by National Health Service Digital. The data
are entered by the centres themselves into the NACR
database. This database includes information
concerning the patients’ demographic and anthropo-
metric details, initial event, risk factors, treatment,
medications, physical activity status and clinical
outcomes following CR.10
Patients were included in the analysis if they were
adults (>18 years); were postmyocardial infarction,
coronary artery bypass grafting, percutaneous coronary
intervention or valve surgery patients; had already
been assessed at baseline before starting CR; had
undertaken the ISWT and hence their fitness had been
assessed and their age, gender, height, weight, BMI
and comorbidities had also been recorded.
Incremental shuttle walk test
In this test, the patient walks a 10 metre course, known as
a shuttle. The patient walks continuously back and forth
between two cones and an audio signal dictates the
walking speed. The test has 12 levels, at each level the
number of shuttles the patient is required to walk
increases. The test ends when the patient completes the
12 levels, achieves 80% of the maximum heart rate
(HRmax= 220 age), rate perceived exertion (RPE) is
more than 15, is no longer able to keep up with the audio
signal, or is too breathless. When the patient finishes the
test, the number of shuttles, and hence the distance
covered, is recorded.20 21
Statistical analysis
Data were presented as mean and standard deviation
(SD). An independent t-test was used to determine the
differences between men and women at baseline. Pear-
son’s correlation was used to study the relationship
between outcome and the potential predicted variables.
By accounting for age, the difference in the distance
walked between men and women was assessed using
two-way ANOVA. Stepwise multiple regression analysis
was used to investigate which factors predict ISWT
distance. Age, gender, BMI, height and weight; pres-
ence of hypertension, dyslipidemia or diabetes;
smoking (yes, no) and physical activity level at baseline
based on meeting the 150min/week recommendation
(yes, no) were entered into the regression as indepen-
dent variables. The key outcome was the distance
covered in metres during the ISWT. Prior to the anal-
ysis, it was decided to consider only variables which
explained more than 5% of the variance. The assump-
tions of the regression model were checked and there
were no violations.
The 25th, 50th and 75th percentiles of the distance
walked were produced to provide reference values. Data
were analysed using Statistical Package for Social Science
V.23. A p value <0.05 is considered to be significant.
RESULTS
The study population comprised patients from 48 centres
in the UK who had undertaken the ISWT as a baseline
assessment (figure 1). Of the 8863 patients, 6893
(77.78%) were male and 1970 (23.22%) were female.
The patient demographics and the baseline charac-
teristics are summarised in table 1. The mean age of
the group was 63.2611.09 years and ranged from
20 to 99 years; the mean BMI was 27.864.56 kg/m2
(table 1). There was a significant difference between
the ages of men and women (62.711 vs
65.1111.24, p<0.001), respectively. Men were also
significantly taller (174.277.00) than women
(160.166.64). The mean distance covered by the
overall sample was 358.11174.40 m. After taking
account of age in the analysis, the men walked signif-
icantly further than women (384.24175.41 mand
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266.58135.94 m, p<0.001, respectively). The most
prevalent comorbidities among the participants were
hypertension, dyslipidemia and diabetes. Seven per
cent of the participants were smokers (table 1).
Stepwise regression analysis using age and gender
explained 27% of the variance in the distance covered
during the ISWT. Age was the best predictor
explaining 21% of the variance in the ISWT distance
(r=0.455, R2=0.21, adjustedR2=0.21 SEE=155.4,
p<0.001). The strength of prediction was further
improved by adding gender (R2=0.27, adjusted
R2=0.27, SEE=148.7, p<0.001) (table 2).
Figure 1 Patient flowchart for cardiac rehabilitation.
Table 1 Patient demographics and baseline characteristics
Factor Total sample Male Female
Sample size n=(8863) n=6893 (77.8%) n=1970 (23.2%)
Age (years) 63.2611.09 62.7311 65.1011.25
Height (cm) 171.149.11 174.277 160.166.64
Weight (kg) 81.8015.51 84.7814.4 71.4014.8
BMI (kg/m2) 27.864.56 27.894.29 27.815.42
ISWT (m)* 358.11174.40 384.24 m175.41 266.58135.94
Hypertension (%) 40.1 39.0 43.0
Dyslipidemia (%) 31.3 31.2 31.8
Diabetes (%) 16.0 16.2 15.5
Physical activity (%) 40.5 43.0 33.0
Smokers (%) 7.3 7.2 7.7
MI (%) 8.6 7.3 13.0
PCI (%) 60.1 60.8 57.3
CABG (%) 22.1 24.4 14.2
Valve surgery (%) 9.2 7.4 15.6
BMI, body mass index; CABG, coronary artery bypass grafting; ISWT, incremental shuttle walk est; MI, myocardial infarction; PCI,
percutaneous coronary intervention.
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The equation developed in this study to predict the
ISWT distance was:
719.2 (6.95xage)+(101.18xgender) (Where male=1
and female=0)
None of the following variables; BMI, height, weight,
smoking, physical activity level or the presence of
hypertension, dyslipidemia and diabetes made no
considerable contribution as predictors to the model.
Tables 3 and 4 show the age-related reference
values according to patient gender. In each age band,
the distances walked by women were significantly
shorter than those walked by men. There was an
inverse relationship between the values of distance
walked and age bands for both men and women. The
youngest age group (44 years) for both genders
walked the farthest and the oldest age group (80)
walked the shortest distance, and this remained true
for each centile value.
DISCUSSION
In this study, the factors which best predict the distance
covered in the ISWT and the reference values for this
distance at the baseline of the CR assessment were
produced using national level data from routine
clinical practice. The main findings of this study were
that age and gender were significant predictors of the
variance in distance walked during the ISWT.
The results indicated that age was the best predictor
explaining 21% of the variance in the distance covered
and was inversely correlated with fitness. It was
reported that the direction of this correlation might be
due to changes which occur in parallel with ageing
such as cardiovascular responses related to a decrease
in the maximal heart rate, arteriovenous oxygen differ-
ence, ejection fraction and a reduction in maximal
cardiac output,22–24 or the decrease in maximal oxygen
uptake and a reduction in both muscle mass and
muscle strength.13 This 21% value is in agreement with
the result reported in the study by Cardoso et al11 in
female participants, higher than the 4% reported in a
previous study in healthy subjects.14 This study found
that gender explained 6% of the variance, which is in
agreement with the study by Dourado et al; however,
gender was reported to explain more in the study by
Cardoso et al (11%).
The current results explained more of the variance in
distance walked than that reported in previous studies
in a similar CR population.11 12 The study conducted
Table 2 Predictor variables for distance walked in the ISWT
Variable Unstandardised coefficient (b) 95%CI p Value
Age  6.95  7.23 to   6.67 >0.001
Gender 101.18 93.70 to 108.66 >0.001
Constant 719.20 699.80 to 738.60 >0.001
ISWT, incremental shuttle walk test
Table 3 Centile values for total distance walked during
the ISWT by female patients assessed at entry to
outpatient cardiac rehabilitation
Women
age band
(years)* Sample
C
25
C
50
C
75 Mean SD
44 88 300 375 500 402 167
45–49 115 270 350 440 366 151
50–54 141 250 330 440 342 151
55–59 236 220 290 390 310 142
60–64 254 200 270 360 285 125
65–69 379 180 250 340 262 116
70–74 337 150 220 290 228 103
75–79 271 130 190 260 200 91
80 149 100 160 200 160 86
*Age bands (years), in 5-year increments.
C, centile value for distance walked in metre; ISWT, incremental
shuttle walk test.
Table 4 Centile values for total distance walked during
the ISWT by male patients assessed at entry to
outpatient cardiac rehabilitation
Men
Age band
(years)* Sample
C
25
C
50
C
75 Mean SD
44 357 420 520 630 519 193
45–49 473 370 510 620 497 182
50–54 798 340 460 570 470 182
55–59 985 330 420 540 435 176
60–64 1085 280 380 490 391 156
65–69 1209 270 360 450 366 141
70–74 926 220 330 420 321 134
75–79 701 180 250 330 264 118
80 359 140 200 280 214 107
*Age bands (years), in 5-year increments.
C, centile value for distance walked in metres; ISWT, incremental
shuttle walk test
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recently by Cardoso et al reported that age, height and
the presence of diabetes explained 24% and 25% of the
variance in the distance walked by female and male
participants, respectively, while in men, an additional
significant predictor was BMI. However, in that study,
the results for the female participants were based on a
very small sample of patients with diabetes (n=35),
whereas, in this study (n=8863), the presence of
diabetes did not contribute significantly to the explana-
tion of the variance in either men or women. In the
earlier study by Pepera et al12, height and BMI
explained 20% of this variance; however, unlike in the
current study, neither age nor gender were significant
predictors, which might be due to the lower age range of
the participants and the small sample of women.
Conversely, the results from this study showed a
lower R2 value (R2=0.27, adjusted R2=0.27,
SEE=148.7, p<0.001) than that reported in previous
studies where reference equations were developed to
predict the distance covered during ISWT in a
healthy population.13–17 However, the protocol of the
ISWT was extended in these studies from 12 to 15
levels to avoid the ceiling effect,13–15 whereas in a
typical CR patient, achieving a distance over and
above the standard ISWT (12 levels) is unlikely.10
Reference values
On the basis of the results obtained from this study, we
have created reference values according to age and
gender. Age was the stronger predictor and gender, in
addition to its modest predictive function, is routinely
used in literature to differentiate fitness values.1 11 25 26
The practical implications of these reference values are
to guide practitioners’ expectations about how well
patients might perform in an ISWT, to assist in the initial
interpretation of the ISWT results to assess the need for a
second test, to help patients understand their fitness level
in relation to their peers and to set realistic goals to
improve their physical condition as part of the CR
intervention.
As mentioned previously, there is only one study which
has attempted to produce ISWT reference values for the
CR population.11 Cardoso et al produced reference
values for patients who joined the outpatient CR
programme based on 547 patients: 132 women and 415
men. The patients were divided into age bands at 5-year
intervals from 25 to 90 (13 bands) according to gender.
However, the use of these reference values might be
considered unrealistic due to the small number of partic-
ipants, most notably fewer females, which resulted in an
average number of approximately 10 participants in
each band. In addition, the data were obtained from only
four UK hospitals, compared with 48 CR programmes in
this study, which might be considered unrepresentative
of the general population with cardiac disease.
In this study, we divided the group into nine bands,
seven of them at 5-year intervals. The two remaining
bands, namely the first and the last band, were larger
as we found that there was no significant difference in
the mean of the ISWT distance walked between the
patients within each of these marginal bands regardless
of age. The median distance walked by men and
women in the youngest age band (44 years) was 520
m and 375 m, respectively, which was more than twice
the distance walked in the oldest age band (80 years)
at 200 m for men and 160 m for women. We used the
25th and 75th percentiles as they are a useful guide for
CR practitioners to evaluate baseline score and assist
with goal setting as part of core CR delivery.
The major strength of this study was the large
sample, covering a wide age range in the CR popula-
tion suffering from different comorbidities, which was
sufficient to enable the analysis. However, the study
was not without limitations. Due to the retrospective
nature of the study, some significant predictors that
were reported in previous studies were not found in
the NACR database such as resting heart rate, rate of
perceived exertion and hand strength grip, and so
these were not taken into consideration.16
The normative values proposed in this article assume
that the ISWTwas carried out in a rigorous way but we are
unable to substantiate this. The test is supported by a
clinician, and the patient follows the verbal and bleep
commands from the ISWT audio recording, which gives
some confidence that it was delivered in a consistent
manner.
Conclusion
Age and gender were the commonly determined key
factors in predicting the ISWT distance in the CR
population, with age being the best predictor. The
reference values produced in this study represent a
valuable tool to be used in a clinical setting. These
findings may assist practitioners in their initial expecta-
tions of patients’ performance in the ISWT, enable
them to interpret the test results to better inform
patients of their fitness level and potentially aid
patients in the setting of realistic CR goals in respect to
their walking ability.
Implications for practice
" Reference values in this study have the potential to be used as
a tool to help guide CR practitioners’ expectations of ISWT
performance.
" These values can inform practitioners of the need to perform a
second ISWT test.
" Reference values enable CR patients to understand their age
and gender-related walking fitness level prior to starting CR,
which could help set realistic goals.
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